{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Foster City",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {
        "application_number": [
          "NDA214787"
        ],
        "brand_name": [
          "VEKLURY"
        ],
        "generic_name": [
          "REMDESIVIR"
        ],
        "manufacturer_name": [
          "Gilead Sciences, Inc."
        ],
        "product_ndc": [
          "61958-2901",
          "61958-2902"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "REMDESIVIR"
        ],
        "rxcui": [
          "2284960",
          "2367758",
          "2395502",
          "2395504"
        ],
        "spl_id": [
          "2399f66f-aacb-4743-8117-b722c91b4bac"
        ],
        "spl_set_id": [
          "c0978fa8-53ff-4ca2-82a7-567fd3e958ca"
        ],
        "package_ndc": [
          "61958-2902-2",
          "61958-2901-2"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193948"
        ],
        "pharm_class_epc": [
          "SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"
        ],
        "unii": [
          "3QKI37EEHE"
        ]
      },
      "product_type": "Drugs",
      "event_id": "89153",
      "recalling_firm": "Gilead Sciences, Inc.",
      "address_1": "333 Lakeside Dr",
      "address_2": "",
      "postal_code": "94404-1147",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0299-2022",
      "product_description": "Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2",
      "product_quantity": "53,473 vials",
      "reason_for_recall": "Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.",
      "recall_initiation_date": "20211203",
      "center_classification_date": "20211228",
      "termination_date": "20220725",
      "report_date": "20220105",
      "code_info": "Lots: 2141001-1A, 2141002-1A, Exp. 01/2024",
      "more_code_info": ""
    }
  ]
}